ID E3U906_MACMU Unreviewed; 393 AA. AC E3U906; G7NIG9; DT 11-JAN-2011, integrated into UniProtKB/TrEMBL. DT 11-JAN-2011, sequence version 1. DT 27-MAR-2024, entry version 103. DE RecName: Full=Cellular tumor antigen p53 {ECO:0000256|ARBA:ARBA00017135, ECO:0000256|RuleBase:RU003304}; GN Name=TP53 {ECO:0000313|EMBL:ADO78765.1}; OS Macaca mulatta (Rhesus macaque). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; OC Cercopithecidae; Cercopithecinae; Macaca. OX NCBI_TaxID=9544 {ECO:0000313|EMBL:ADO78765.1}; RN [1] {ECO:0000313|EMBL:ADO78765.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=23516500; RA Diehl W.E., Johnson W.E., Hunter E.; RT "Elevated Rate of Fixation of Endogenous Retroviral Elements in Haplorhini RT TRIM5 and TRIM22 Genomic Sequences: Impact on Transcriptional Regulation."; RL PLoS ONE 8:E58532-E58532(2013). RN [2] {ECO:0000313|EMBL:AFH28962.1} RP NUCLEOTIDE SEQUENCE. RC TISSUE=Testis {ECO:0000313|EMBL:AFI34822.1}, and Thymus RC {ECO:0000313|EMBL:AFH28962.1}; RX PubMed=25319552; DOI=10.1186/1745-6150-9-20; RA Zimin A.V., Cornish A.S., Maudhoo M.D., Gibbs R.M., Zhang X., Pandey S., RA Meehan D.T., Wipfler K., Bosinger S.E., Johnson Z.P., Tharp G.K., RA Marcais G., Roberts M., Ferguson B., Fox H.S., Treangen T., Salzberg S.L., RA Yorke J.A., Norgren R.B.Jr.; RT "A new rhesus macaque assembly and annotation for next-generation RT sequencing analyses."; RL Biol. Direct 9:20-20(2014). CC -!- FUNCTION: Acts as a tumor suppressor in many tumor types; induces CC growth arrest or apoptosis depending on the physiological circumstances CC and cell type. Involved in cell cycle regulation as a trans-activator CC that acts to negatively regulate cell division by controlling a set of CC genes required for this process. One of the activated genes is an CC inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be CC mediated either by stimulation of BAX and FAS antigen expression, or by CC repression of Bcl-2 expression. {ECO:0000256|RuleBase:RU003304}. CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000256|PIRSR:PIRSR602117-1, CC ECO:0000256|RuleBase:RU003304}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000256|PIRSR:PIRSR602117-1, CC ECO:0000256|RuleBase:RU003304}; CC -!- SUBUNIT: Binds DNA as a homotetramer. {ECO:0000256|RuleBase:RU003304}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing CC center, centrosome {ECO:0000256|ARBA:ARBA00004300}. Cytoplasm CC {ECO:0000256|RuleBase:RU003304}. Nucleus CC {ECO:0000256|RuleBase:RU003304}. Endoplasmic reticulum CC {ECO:0000256|ARBA:ARBA00004240}. Mitochondrion matrix CC {ECO:0000256|ARBA:ARBA00004305}. Nucleus, PML body CC {ECO:0000256|ARBA:ARBA00004322}. CC -!- SIMILARITY: Belongs to the p53 family. {ECO:0000256|ARBA:ARBA00006167, CC ECO:0000256|RuleBase:RU003304}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; HM104190; ADO78765.1; -; mRNA. DR EMBL; HM104191; ADO78766.1; -; mRNA. DR EMBL; JU472158; AFH28962.1; -; mRNA. DR EMBL; JU472159; AFH28963.1; -; mRNA. DR EMBL; JU472160; AFH28964.1; -; mRNA. DR EMBL; JV044751; AFI34822.1; -; mRNA. DR RefSeq; NP_001040616.1; NM_001047151.2. DR AlphaFoldDB; E3U906; -. DR SMR; E3U906; -. DR GeneID; 716170; -. DR KEGG; mcc:716170; -. DR CTD; 7157; -. DR HOGENOM; CLU_019621_0_0_1; -. DR OrthoDB; 2902631at2759; -. DR GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell. DR GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell. DR GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0000976; F:transcription cis-regulatory region binding; IEA:InterPro. DR GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; IEA:UniProt. DR GO; GO:0051262; P:protein tetramerization; IEA:InterPro. DR GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW. DR CDD; cd08367; P53; 1. DR Gene3D; 2.60.40.720; -; 1. DR Gene3D; 6.10.50.20; -; 1. DR Gene3D; 4.10.170.10; p53-like tetramerisation domain; 1. DR InterPro; IPR008967; p53-like_TF_DNA-bd_sf. DR InterPro; IPR012346; p53/RUNT-type_TF_DNA-bd_sf. DR InterPro; IPR011615; p53_DNA-bd. DR InterPro; IPR040926; p53_TAD2. DR InterPro; IPR036674; p53_tetramer_sf. DR InterPro; IPR010991; p53_tetrameristn. DR InterPro; IPR013872; p53_transactivation_domain. DR InterPro; IPR002117; p53_tumour_suppressor. DR PANTHER; PTHR11447; CELLULAR TUMOR ANTIGEN P53; 1. DR PANTHER; PTHR11447:SF6; CELLULAR TUMOR ANTIGEN P53; 1. DR Pfam; PF00870; P53; 1. DR Pfam; PF08563; P53_TAD; 1. DR Pfam; PF07710; P53_tetramer; 1. DR Pfam; PF18521; TAD2; 1. DR PRINTS; PR00386; P53SUPPRESSR. DR SUPFAM; SSF47719; p53 tetramerization domain; 1. DR SUPFAM; SSF49417; p53-like transcription factors; 1. DR PROSITE; PS00348; P53; 1. PE 2: Evidence at transcript level; KW Activator {ECO:0000256|ARBA:ARBA00023159, ECO:0000256|RuleBase:RU003304}; KW Apoptosis {ECO:0000256|ARBA:ARBA00022703, ECO:0000256|RuleBase:RU003304}; KW Biological rhythms {ECO:0000256|ARBA:ARBA00023108}; KW Cell cycle {ECO:0000256|ARBA:ARBA00023306, ECO:0000256|RuleBase:RU003304}; KW Cytoplasm {ECO:0000256|ARBA:ARBA00022490, ECO:0000256|RuleBase:RU003304}; KW DNA-binding {ECO:0000256|RuleBase:RU003304}; KW Isopeptide bond {ECO:0000256|ARBA:ARBA00022499}; KW Metal-binding {ECO:0000256|ARBA:ARBA00022723, KW ECO:0000256|PIRSR:PIRSR602117-1}; Necrosis {ECO:0000256|ARBA:ARBA00022590}; KW Nucleus {ECO:0000256|RuleBase:RU003304}; KW Phosphoprotein {ECO:0000256|ARBA:ARBA00022553}; KW Repressor {ECO:0000256|ARBA:ARBA00022491}; KW Transcription {ECO:0000256|RuleBase:RU003304}; KW Transcription regulation {ECO:0000256|RuleBase:RU003304}; KW Zinc {ECO:0000256|ARBA:ARBA00022833, ECO:0000256|PIRSR:PIRSR602117-1}. FT DOMAIN 6..30 FT /note="p53 transactivation" FT /evidence="ECO:0000259|Pfam:PF08563" FT DOMAIN 35..59 FT /note="Cellular tumor antigen p53 transactivation" FT /evidence="ECO:0000259|Pfam:PF18521" FT DOMAIN 100..288 FT /note="p53 DNA-binding" FT /evidence="ECO:0000259|Pfam:PF00870" FT DOMAIN 319..357 FT /note="p53 tetramerisation" FT /evidence="ECO:0000259|Pfam:PF07710" FT REGION 48..97 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 283..325 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 352..393 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 70..92 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 304..319 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 366..380 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 176 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000256|PIRSR:PIRSR602117-1" FT BINDING 179 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000256|PIRSR:PIRSR602117-1" FT BINDING 238 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000256|PIRSR:PIRSR602117-1" FT BINDING 242 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000256|PIRSR:PIRSR602117-1" SQ SEQUENCE 393 AA; 43655 MW; E212E5E4FE650103 CRC64; MEEPQSDPSI EPPLSQETFS DLWKLLPENN VLSPLPSQAV DDLMLSPDDL AQWLTEDPGP DEAPRMSEAA PPMAPTPAAP TPAAPAPAPS WPLSSSVPSQ KTYHGSYGFR LGFLHSGTAK SVTCTYSPDL NKMFCQLAKT CPVQLWVDST PPPGSRVRAM AIYKQSQHMT EVVRRCPHHE RCSDSDGLAP PQHLIRVEGN LRVEYSDDRN TFRHSVVVPY EPPEVGSDCT TIHYNYMCNS SCMGGMNRRP ILTIITLEDS SGNLLGRNSF EVRVCACPGR DRRTEEENFR KKGEPCHQLP PGSTKRALPN NTSSSPQPKK KPLDGEYFTL QIRGRERFEM FRELNEALEL KDAQAGKEPA GSRAHSSHLK SKKGQSTSRH KKFMFKTEGP DSD //